Scotia Holdings PLC

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in

UK biotech is struggling through a winter almost as harsh as that brought on by British Biotech PLC during the mid-nineties. This time, though, it's not just about one product failure at one compan

Some of Germany's fast-growing biotechs are developing their own approach to building successful businesses, seeking a middle ground between platform technology and product models. by Melanie A. Senio

Want a fast, low-risk route to an approved drug? Develop somebody else's clinical-stage therapeutic. But to get a reasonable return on investment, you need to bring value the originator couldn't. by R